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Abstract: Aims: Rates of certain
histopathologic features were evaluated in
hepatitis C and in hepatitis B materials and
analyzed statistically in a Turkish population.
Method: The presence of lymphoid
aggregate, steatosis, ductal lesions, sinusoidal
inflammation and portal iron deposition were
investigated in 80 hepatitis C and 104
hepatitis B specimens and evaluated using the
chi-square test and Fisher’s exact test. Pan B
and T cell markers were used for lymphoid
aggregate analysis. P53 and PCNA were
applied for the possible impact of steatosis on
cell biology.
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Results: All mentioned parameters excluding
sinusoidal inflammation were found to be

Introduction
Chronic hepatitis is not a single disease, but rather a
clinical and pathological syndrome, which has several
causes (1). Liver biopsy is of major importance in the
evaluation of patients with chronic hepatitis. The
histological features of chronic hepatitis have been
studied extensively and certain characteristic
morphological features have been ascribed to chronic
hepatitis of differing origins.
Histopathological changes in chronic hepatitis C have
been described in previous reports (2,3). A histologic
pattern of mild chronic hepatitis with portal lymphoid
aggregate and/or follicles, varying degrees of bile duct
damage, lymphocytic infiltration of sinusoids and
steatosis was found to be more frequent than other
chronic hepatitis. However, in some chronic hepatitis B
cases, similar histologic findings are seen (4).
In the present study, our aim was to determine the
rate and significance of these features in hepatitis C by
comparing their presence in hepatitis B. The intraportal
lymphoid cell population in both groups was analyzed.

higher in hepatitis C samples. The co-presence
of lymphoid aggregate and ductal lesions was
found to be significant in hepatitis C. The
distribution of T and B cells was similar in
both groups. P53 and PCNA expressions were
found to be non-significant in both groups.
Conclusion: Our results except sinusoidal
inflammation were thought to be in
correlation with the reports in the literature.
Lower rates of iron deposition might be
related to geographic differences that could
be observed as a feature of the C virus.
Key Words: Hepatit B virus, Hepatit C virus,
histopathology, P53, PCNA

The presence of viral markers of each type were
investigated immunohistochemically in order to
determine their significance and reliability in the
diagnosis. The samples with steatosis were stained with
anti-PCNA and anti-P53 for their possible relation with
carcinogenesis (5).

Materials and Methods
Needle biopsy samples fixed in 10% neutral formalin
belonging to 80 hepatitis C and 104 hepatitis B cases
were included. The patients in the first group were all
seropositive for antiHCV, whereas the second group’s
patients had HBs antigen in their sera. In addition to the
routine H&E stain, various other stains like periodic acid
Schiff (PAS) with and without diastase digestion for bile
duct injury, Masson’s trichrome and reticuline for
fibroblastic stage and Prussian blue for iron deposition
were performed.
Five histological features were defined and evaluated
as follows:
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1. Lymphoid aggregates/follicles in portal tracts:
Follicles consisting of a germinal center with
surrounding small lymphocytes or a densely
packed collection of small lymphocytes within a
portal tract, typically near an interlobular bile
duct, were assessed (Figure 1).
2. Bile duct damage (Figure 1): Bile duct damage is
characterized by a lymphocytic infiltrate
surrounding the interlobular bile ducts. These
inflammatory cells may be found between the
epithelial cells or migrate through the basement
membrane. Beyond this inflammation, loss of
polarity, variations in nuclear chromaticity,
cytoplasmic vacuolization and mitotic activity in
epithelial cells are part of the damage.
3. Fatty change (Figure 2): Large and small droplet
vacuoles were defined as absent, mild, moderate
and marked.
4. Activation of sinusoidal inflammatory cells
(Figure 3): The prominence of lymphocytes and
Kupffer cells in sinusoids, in a “beads-on-astring” pattern, was evaluated as present or
absent.
5. Iron deposition (Figure 4): Only portal iron
depositions in macrophages and especially in the
venous endothelial cells were noted as present or
absent.
Immunhistochemical studies.
The presence of viral antigens in the liver was shown

Figure 1.
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(HE x 200) Lymphoid aggregate close to bile duct.

by using antiHBs (Dako-Copenhagen, Denmark), antiHBc
(Dako-Copenhagen, Denmark) for the B virus and
antiHCV (Signet-Dedham, USA) for the C virus. The
phenotype of immunocompetent cells present in and
around intraportal lymphoid nodules was analyzed with
pan T (CD43-DAKO-Copenhagen, Denmark) and pan B
(CD20-DAKO-Copenhagen, Denmark) markers.
Thirty-one hepatitis B and 40 hepatitis C materials
having steatosis were stained with antiP53 (DAKO,
Copenhagen-Denmark) and antiPCNA (BiogenexCalifornia, USA).
After deparaffinization and hydration steps, 4micrometer thick sections were stained by the
streptavidin-biotin peroxidase indirect technique.
Diaminobenzidine (DAB) or AEC was used as the
chromogen.
Statistical analysis
The results were evaluated with Chi-square and
Fisher’s exact tests. Probability values less than 0,05
were considered significant.

Results
The frequencies of each histologic feature in biopsy
specimens from HCV and HBV groups are shown in Table
1. Activation of sinusoidal cells, reflecting the lobular
inflammatory component of chronic hepatitis, was
observed in 18 (22,5%) of 80 HCV cases and 45 (45%)
of 104 HBV cases. The higher incidence in B hepatitis was
found to be significant (p<0,05).

Figure 2.

(HE x 200) Large droplet fatty change in hepatocytes.
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Figure 3.

(HE x 200) Sinusoidal inflammation.

Figure 4.

(Prussian blue x 400) Portal iron deposition in
macrophages and endothelial cells.

Figure 5.

(AEC x 200) CD43 positive cells in the portal-periportal
area.

Figure 6.

(AEC x 200) CD20 positive cells in the portal-periportal
area.

Other histologic features, namely, steatosis, bile duct
injury, lymphoid aggregate formation and portal iron
deposition in HCV materials were observed at the
following rates respectively: 61 (75%), 36 (45%), 46
(60%) and 12 (15%). We observed steatosis in 62
(60%), bile duct injury in 28 (27%), lymphoid aggregate
formation in 27 (24%) and portal iron deposition in 7
(5%) of 104 hepatitis B samples.
On statistical analysis, steatosis, bile duct injury and
lymphoid aggregate formation were found to be
significantly higher in hepatitis C than hepatitis B
(p<0,05). Although portal iron deposition was seen more
frequently in C cases, the difference was not significant.
Immunhistochemically, lymphoid aggregates showed
similar cellular populations in both hepatitis C and B

samples. While portal inflammation and the peripheral
zone of lymphoid aggregate were stained with T cell
marker prominently, B cell dominancy was observed in
the middle of the aggregate (Figures 5 and 6).
Immunhistochemically, the viral markers were shown
in 96 (95%) of 104 hepatitis B samples. While all 96
cases were positive with antiHBs, only 44 of 96 were
stained with antiHBc. Detection of antiHCV was as low as
22, only 27,5% of all hepatitis C cases (Table 1).
The possible impact of steatosis on molecular
carcinogenesis was examined using antiP53 and antiPCNA
stains. Forty hepatitis C and 31 hepatitis B samples all
having certain amount of steatosis were chosen for this
purpose. Only nuclear staining was noted for both
antibodies. P53 expression was seen in 4 of (6%) the
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Steatosis

Sinusoidal
Inflammation

Bile Duct
Lesion

Lymphoid
Aggregate

Portal Iron
Deposition

Viral Marker
Tissue Positivity

HBV

62 (60%)

45 (45%)

28 (27%)

27 (24%)

7 (5%)

96 (95%)

HCV

61 (75%)

18 (22.5%)

36 (45%)

46 (60%)

12 (15%)

22 (27.5%)

Table 2.

P53/PCNA positivity in materials with steatosis.
P53

Table 1.

Histologic features and rates of
viral markers.

hepatitis C and 104 hepatitis B liver biopsy specimens was
examined to determine if any of these features
distinguishes HCV from HBV infection.

PCNA

+

-

+

-

HBV

3

28

6

25

HCV

4

36

17

23

Although the above-mentioned lesions were observed
in both groups, the best set of histological lesions, three
features statistically more likely to be associated with
hepatitis C, were lymphoid aggregate formation (HCV
60%, HBV 24%), bile duct damage (HCV 45%, HBV
27%) and steatosis (HCV 75%, HBV 60%). These lesions
have also been described as histologic markers of chronic
hepatitis C in various studies (2-4).
The hepatitis C virus is related to flaviviruses and
pestiviruses and cell damage has been attributed to its
direct cytopathic effect (6). Fatty change appears to fall
into this category, and although it may be present in
hepatitis B cases, it seems to be more severe and
extensive in hepatitis C materials.

Figure 7.

(DAB x 200) Nuclear PCNA positivity.

hepatitis C and 3 of (4%) the hepatitis B cases. PCNA
staining (Figure 7) was shown in 6 of (8%) the hepatitis
B and 17 (24%) of the hepatitis C cases (Table 2). There
was no significant difference between the two groups for
P53 and PCNA staining.

Discussion
Some chronic hepatitis types have certain
characteristic histologic features (1). Although no
pathognomonic cellular marker of HCV infection has been
shown to date, a number of histological findings have
been cited for their potential diagnostic value, including
bile duct damage, lymphoid follicles and/or aggregates
within portal tracts, fatty change and sinusoidal reaction.
In the present study, the frequency of these lesions in 80
408

In our previous study, we detected notable rates of
P53 overexpression in the materials of steatohepatitis
and some nonviral chronic hepatitis materials with
steatosis (7). In contrast, in the present study, very few
cases of both viral hepatitis groups were stained
positively with antiP53 and there were no significant
difference between them (Table 2). Steatosis in viral
hepatitis may be a different cytological alteration, which
does display itself as a mutagenic phenotype but just as an
innocent viral effect (8-10). Proliferating cell nuclear
antigen (PCNA) expression was higher in hepatitis C
materials than in hepatitis B materials. However, the
positive cell rate was hardly more than 5% of all
hepatocytes and this finding was in the normal ranges of
the positivity for PCNA in the liver. Nuclear
pleomorphism, which is not very uncommon in liver
biopsies, seems to affect the positive staining rates
(7,11).
Intraportal lymphoid aggregates and/or follicles are
located close to interlobular bile ducts or surround them
in both hepatitis C and hepatitis B materials. In the
pathogenesis of these lesions, immunologically mediated
reactions are suggested (12,13).
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Improvement of these lesions after interferon a
treatment has been reported and seems to reflect
immune pathogenesis (14). The aggregates showed
similar cellular population in both groups and while portal
and periportal cells were positive with CD43, B cell
dominancy was observed in the middle of the aggregates.
Our immunophenotyping findings were similar to those in
previous studies in which no differences have been
reported between chronic hepatitis C or B and
autoimmune hepatitis (12-14). In this context, they seem
to be true functional lymphoid follicles resembling lymph
nodes (14). In a recent study the authors focused on B
cell response and extensively analysed B cell activation,
proliferation and maturation in the livers of patients with
chronic hepatitis C (14). They found similar lymphoid
marker expressions with lymph nodes and concluded that
the liver is a potential secondary lymphoid organ. The
reason why HCV infection preferentially induces the
formation of functional B cell response in the liver is
currently unclear. However, our results, in accordance
with those in the literature, suggest that lymphoid
aggregates/follicles are not unique but are a characteristic
feature of chronic hepatitis C. Intraportal lymphoid
aggregate formations and bile duct injury can be seen in
some other nonviral liver diseases like autoimmune
hepatitis and primary biliary cirrhosis (15). None of the
patients in either group had serologic immune markers,
and no histological features of autoimmune hepatitis like
plasma cell dominancy, periportal liver cell rosettes or
severe necroinflammatory reaction were observed.
The duct damage was not severe and did not seem to
end with destruction in our materials. Since it is always
located close to lymphoid reaction and bile duct
epithelium expresses histocompability (HLA) antigens, the
presence of a lesion appears to be related with immune
reaction. Because of the higher frequency of bile duct
injury in hepatitis C than in hepatitis B, we assumed that
this lesion was another characteristic feature of viral
hepatitis C.
During the past few years, there has been much
interest in the role of iron in viral hepatitis (16). Iron has
long been known to be an essential element for the
replication of all organisms, including virulent
microorganisms. Stainable iron is found commonly in
liver biopsy specimens of patients with acute or chronic

viral hepatitis. Hemosiderin and lipofuchsin were defined
in Kuppfer cells and this finding was related to repair
after injury (17). The implication was that the iron found
in the liver in viral hepatitis had been released from
hepatocytes damaged by the virus.
Farinati et al. addressed the question of whether HCV
may have a direct cytopathic effect on hepatocytes
through the activation of iron dependent lipid
peroxidation (18). Their results were interpreted as
suggesting that mechanisms of hepatocyte damage are
different in hepatitis B and C and that the altered iron
metabolism and iron accumulation in hepatitis may be
related to an effect of the virus itself on hepatocytes or
possibly on the immune cells of the liver. In our study,
iron deposition was observed more frequently in hepatitis
C than hepatitis B but the difference was not statistically
significant. The localization of iron deposition was similar
but deposition in portal macrophages and venous
endothelial cells was noted more in hepatitis C materials.
Barton et al. were first to stress the importance of portal
distribution of a hepatic iron as a predictor of poor
response to IFNa (19). It was speculated that iron in
portal endothelial cells could interfere with their functions
during the inflammatory process, such as clearance of the
virus, or could participate in immune mediated reaction
(20). However, they did not detect any significant
differences between the cases of hepatitis B, C or
autoimmune hepatitis according to iron deposition
localization (19).
The number of samples showing iron deposition in
our study was not as high as reported in the literature.
But there have been some reports about similar
observations from Israel (16).
We speculate that this could be due to differences in
the type and geographic distribution of the virus, which is
a very well known feature of the C virus. Thus further
investigations about serum iron and iron binding protein
analyses in correlation with different viral genotypes,
which are beyond the scope of this study, may be needed.
Correspondence author:
Özlem SÜER
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